Treatment-resistant schizophrenia - a RCT on the effectiveness of repeated-dose sodium nitroprusside (2021)
- Authors:
- Autor USP: HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.schres.2021.03.005
- Subjects: ANTIPSICÓTICOS; MÉTODO DUPLO-CEGO; ESQUIZOFRENIA; FARMACOTERAPIA; RESULTADO DE TRATAMENTO
- Keywords: Clinical trial; Nitric oxide; Schizophrenia; Sodium nitroprusside; Glutamate
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Schizophrenia Research
- ISSN: 0920-9964
- Volume/Número/Paginação/Ano: v. 231, p. 70-72, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ADELINO, Marcelo P. M. et al. Treatment-resistant schizophrenia - a RCT on the effectiveness of repeated-dose sodium nitroprusside. Schizophrenia Research, v. 231, p. 70-72, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2021.03.005. Acesso em: 14 fev. 2026. -
APA
Adelino, M. P. M., Nunes, M. V., Nunes, M. F. Q., Costa, E. R., Ajub, E., Mitrovitch, M. P. B., et al. (2021). Treatment-resistant schizophrenia - a RCT on the effectiveness of repeated-dose sodium nitroprusside. Schizophrenia Research, 231, 70-72. doi:10.1016/j.schres.2021.03.005 -
NLM
Adelino MPM, Nunes MV, Nunes MFQ, Costa ER, Ajub E, Mitrovitch MPB, Ushirohira JM, Quarantini LC, Hallak JEC, Lacerda ALT. Treatment-resistant schizophrenia - a RCT on the effectiveness of repeated-dose sodium nitroprusside [Internet]. Schizophrenia Research. 2021 ; 231 70-72.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.schres.2021.03.005 -
Vancouver
Adelino MPM, Nunes MV, Nunes MFQ, Costa ER, Ajub E, Mitrovitch MPB, Ushirohira JM, Quarantini LC, Hallak JEC, Lacerda ALT. Treatment-resistant schizophrenia - a RCT on the effectiveness of repeated-dose sodium nitroprusside [Internet]. Schizophrenia Research. 2021 ; 231 70-72.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.schres.2021.03.005 - Psychotic syndrome secondary to meningioma treated with a low dose of olanzapine. [Carta]
- Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ?
- Disorganized symptoms predicted worse functioning outcome in schizophrenia patients with established illness
- Transtorno de pânico e outros medicamentos
- Psychedelics and Personality
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- Nitric oxide’s involvement in the spectrum of psychotic disorders
- Effects of the natural β-carboline alkaloid harmine, a main constituent of Ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies
- An overview of animal models related to schizophrenia
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Informações sobre o DOI: 10.1016/j.schres.2021.03.005 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003231668.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
